Delayed membranous cranial ossification

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:3034OMIM:155980Q75.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Delayed membranous cranial ossification (also known as delayed cranial ossification or Parietal foramina with cleidocranial dysplasia) is an extremely rare genetic skeletal disorder characterized by a significant delay in the ossification (bone formation) of the membranous bones of the skull. The cranial vault, which normally forms through intramembranous ossification during fetal and early postnatal development, remains incompletely mineralized, resulting in wide-open fontanelles and large areas of the skull that lack bony coverage at birth and well beyond the normal period of closure. This leaves the brain vulnerable to external trauma during infancy and early childhood. The condition primarily affects the skeletal system, particularly the flat bones of the skull. Key clinical features include widely patent fontanelles, delayed closure of cranial sutures, and parietal bone defects. Additional skeletal anomalies may be present, including clavicular hypoplasia or aplasia, which overlaps with features seen in cleidocranial dysplasia. Affected individuals may also demonstrate wormian bones (small irregular bones within cranial sutures). Neurological development is typically normal unless complications from the cranial defects arise. There is no specific curative treatment for delayed membranous cranial ossification. Management is primarily supportive and protective, focusing on safeguarding the brain during the period of incomplete skull ossification. Protective headgear may be recommended for infants and young children. In some cases, surgical intervention such as cranioplasty may be considered if the cranial defects do not close spontaneously over time. Regular monitoring by a multidisciplinary team including geneticists, pediatric neurosurgeons, and orthopedic specialists is recommended.

Also known as:

Clinical phenotype terms— hover any for plain English:

Decreased skull ossificationHP:0004331
Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Delayed membranous cranial ossification.

View clinical trials →

No actively recruiting trials found for Delayed membranous cranial ossification at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Delayed membranous cranial ossification community →

No specialists are currently listed for Delayed membranous cranial ossification.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Delayed membranous cranial ossification.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Delayed membranous cranial ossificationForum →

No community posts yet. Be the first to share your experience with Delayed membranous cranial ossification.

Start the conversation →

Latest news about Delayed membranous cranial ossification

No recent news articles for Delayed membranous cranial ossification.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Delayed membranous cranial ossification

What is Delayed membranous cranial ossification?

Delayed membranous cranial ossification (also known as delayed cranial ossification or Parietal foramina with cleidocranial dysplasia) is an extremely rare genetic skeletal disorder characterized by a significant delay in the ossification (bone formation) of the membranous bones of the skull. The cranial vault, which normally forms through intramembranous ossification during fetal and early postnatal development, remains incompletely mineralized, resulting in wide-open fontanelles and large areas of the skull that lack bony coverage at birth and well beyond the normal period of closure. This l

How is Delayed membranous cranial ossification inherited?

Delayed membranous cranial ossification follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Delayed membranous cranial ossification typically begin?

Typical onset of Delayed membranous cranial ossification is neonatal. Age of onset can vary across affected individuals.